How do booster shots work

Their level of immunity following the two original doses of the vaccine is lower than people who are not immunocompromised, Sandy said. Do I need a Booster? The rate of severe Covid was almost 20 times lower. However, the researchers acknowledged the data showed only a short-term benefit to booster doses. According to Pfizer, that drop is "due to waning of vaccine immune responses" rather than the delta variant.

The data was collected from July 1 to Aug. In an FDA staff report on Wednesday, the agency's staff advised caution in interpreting data from other countries. Studies done in the United States "may most accurately represent vaccine effectiveness in the U. Ultimately, the FDA staff report declined to take a position on whether the agency should approve booster shots. FDA's vaccine advisory committee is scheduled to meet Friday, Sept.

According to the Financial Times , 10 countries—including Israel, the United States, the UK, and France—have either announced plans for or have already begun administering booster doses to certain parts of their population. Even so, health experts remain divided on the decision, as some argue that any available doses would be better used to vaccinate people in less developed countries.

In the UK, there were just fatalities linked to the virus among fully immunised people between January and July , out of more than 51, These "breakthrough deaths" overwhelmingly occurred in the most vulnerable groups, such as elderly people with weakened immune systems.

In the future, Covid booster doses might be updated each year to match the main viral variants in circulation, just like flu vaccines Credit: Getty Images. As it happens, this is where a booster programme might be at its most useful. For example, a study of organ transplant recipients — who usually need to take drugs to suppress their immune system and prevent it from attacking the donated organ — found that some vaccinated patients had strikingly low antibody levels , which may not have been enough to protect them from Covid So, there is not yet any evidence that waning immunity is leading to more deaths in healthy people — though in some parts of the world it might put pressure on health services, if more people become seriously unwell.

Maria Elena Bottazzi, professor of paediatrics, virology, and microbiology at Baylor College of Medicine in Texas, takes the view that current rates of hospitalisation provide a stronger argument for increasing vaccination rates overall, rather than providing third doses. Again, it helps to turn to the Israel, which experimented with booster doses long before the rest of the world.

One study of fully vaccinated overs found that those who had received a booster dose five months after their second shot had much more potent immunity — they were over 11 times less likely to be infected with Covid, and 19 times less likely to develop severe illness than those who had not received the third dose.

And there are other scraps of evidence from around the world. In a recent trial of booster shots in organ transplant recipients, an international team of scientists found that providing an extra dose of the Moderna vaccine led to a significant jump in several markers of immunity , compared to receiving a placebo. In just nine months, the global population has received around 5. Another hint at the immunological benefits of a third exposure to the Covid spike protein comes from India, where a study of vaccinated healthcare workers — which is yet to be peer-reviewed — recently found that their levels of antibodies declined significantly after four months, unless they had been infected with the virus naturally — which the researchers suggest may have acted as a kind of booster though of course, this is not recommended.

However, even if waning immunity is a major global problem that booster shots can help to overcome it, there are still many things left to work out. In fact, the more you look at the detail, the more complicated it all becomes. In Israel, where most people's first two vaccinations were by Pfizer, this is the vaccine that has been used so far for booster doses. For first and second doses, studies suggest that mixing and matching different Covid vaccine technologies can provide superior immunity to having the same one twice.

However, though the UK began a trial on mix-and-match booster vaccines back in May, there is not yet any data to confirm that this works or is a good idea. While Altmann suspects that boosting with mRNA-based vaccines such as Pfizer and Moderna — which sneak mRNA containing the instructions to make the Covid spike protein into cells, showing them what to look out for — work well, he does have mild concerns about the wisdom of boosting with another kind — the viral vector.

And there's a theoretical possibility that reinfecting yourself with an inactivated virus several times could be a bad idea. The Philippines has recorded over two million Covid cases since the pandemic began, and is now well into its fourth wave Credit: Getty Images. Another question is whether the immunity we gain from booster programmes might last longer if they were designed with updated versions of the vaccines — such as those that can recognise new variants like Delta. Altmann explains that one person walking down the street might have been infected with the original Covid variant, then received two doses of the Pfizer vaccine… then been reinfected with the Delta strain.

Meanwhile, another person may have received a different brand of vaccine, and been infected with a different variant — such as the Alpha strain first identified in Kent. Lancet , — PubMed Article Google Scholar. Mizrahi, B. Thomas, S. Kamar, N. Download references. News 11 NOV Career Guide 10 NOV News 08 NOV Article 10 NOV University of Washington UW.

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily. Advanced search. Skip to main content Thank you for visiting nature. You have full access to this article via your institution. Download PDF. References 1. PubMed Article Google Scholar 5. Close banner Close. Email address Sign up. Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing.